About Retinitis Pigmentosa Retinitis pigmentosa (RP) is a progressive inherited disease of the eye, in which the light-sensitive photoreceptor cells located in the retina degenerate. This results first in the loss of night and peripheral vision, eventually progressing to the loss of central vision and total blindness. It is the leading cause of inherited blindness in the developed world.
The disease, which affects approximately 1.5 million people in the world, has no cure, but thanks to research done at the University of California-Santa Barbara, a new stem cell therapy may soon be available that protects photoreceptor cells from the damaging effects of the gene mutation. So far, only a small number of legally blind patients with RP have begun a trial. The trial is the first attempt to use stem cells to prevent the loss of vision from RP. An experimental injection of retinal stem cells is placed in the eye with the hope that the growth factors from these cells will protect the retinal cells and prevent them from dying, thus preserving the patient’s remaining vision.
The Eye Care & Surgery Center is located at 592 Springfield Avenue, Westfield, New Jersey 07090, 10 Mountain Boulevard, Warren, New Jersey 07059 and 517 Route One South, Suite 1100, Iselin, New Jersey 08830, and is conveniently located for patients from throughout central and northern New Jersey.